21 C.F.R. § 14.100 - List of standing advisory committees

Cite as21 C.F.R. § 14.100
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
68 practice notes
  • In re Medimmune, Inc. Securities Litigation, No. PJM 93-3980.
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Maryland)
    • January 10, 1995
    ...by a team of FDA personnel and, in significant instances, forwarded to an advisory committee of outside experts. See 21 C.F.R. §§ 14.1, 14.100(b)(3). The committee reviews the data and ultimately recommends to the FDA whether the PLA should be approved and for what uses. Respivir proceeded ......
  • Organization, functions, and authority delegations: Biological Response Modifiers Advisory Committee; name change to Cellular, Tissue and Gene Therapies Advisory Committee and function change,
    • United States
    • Federal Register October 28, 2004
    • October 28, 2004
    ...Online via GPO Access [wais.access.gpo.gov] [DOCID:fr28oc04-6] DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 14 Advisory Committee: Change of Name and Function; Technical AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; technical amendment. S......
  • Advisory Committee; Pharmacy Compounding Advisory Committee
    • United States
    • Federal Register January 13, 2014
    • January 13, 2014
    ...DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 14 Docket No. Advisory Committee; Pharmacy Compounding Advisory Committee AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. ----------------------------------------------------------------------- S......
  • Advisory Committee; Food Advisory Committee; Termination
    • United States
    • Federal Register December 13, 2017
    • December 13, 2017
    ...DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 14 Docket No. Advisory Committee; Food Advisory Committee; Termination AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. ----------------------------------------------------------------------- SUMM......
  • Request a trial to view additional results
1 cases
  • 873 F.Supp. 953 (D.Md. 1995), PJM 93-3980, In re Medimmune, Inc. Securities Litigation
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Maryland)
    • January 10, 1995
    ...by a team of FDA personnel and, in significant instances, forwarded to an advisory committee of outside experts. See 21 C.F.R. §§ 14.1, 14.100(b)(3). The committee reviews the data and ultimately recommends to the FDA whether the PLA should be approved and for what uses. Respivir proceeded ......
1 firm's commentaries
66 provisions

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT